On paper the BD device is inferior to the Antares device. Yes. Beyond what Jab said, Rasuvo has an exposed needle - this is a negative attribute, and potentially a strong negative attribute against this product. This can't be danced around and avoided. Most people hate needles (studies, as well as discussions with your MD will affirm this). And I'm not just talking about being stuck by one (i.e. deep muscle injections). Just the sight of needles, and the trauma that comes with knowing you're going to be stuck by "that one" is enough to send some folks over the edge. It gets even worse if you know you have to inject yourself with "that" needle.
Otrexup, unlike Rasuvo, has no exposed needle. In fact, the patient never sees a needle throughout the entire process. They simply pop off the cover of Otrexup, swab the receiving area, hold the device and push down against that area until they hear a click...and they're done. Just to be sure they count to 3, but the drug is administered in half a second. It doesn't get any easier, safer, or anxiety free than that. If a strong co-pay negates any pricing difference (and it will, and that’s IF a pricing difference even exists), which product would the majority of patients prefer?
News 
Market Data 
Discover 
